Christi Shaw

Chief Executive Officer, Kite at Gilead Sciences, Inc.

Christi Shaw

Christi Shaw

Chief Executive Officer, Kite at Gilead Sciences, Inc.

Overview
Career Highlights

Novartis Corporation
Novartis Pharmaceuticals Corp.
Kite Pharma, Inc.

RelSci Relationships

3583

Number of Boards

9

Birthday

1967

Age

54
Contact Data
Trying to get in touch with Christi Shaw? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Christi Shaw likely has professional access to. A relationship does not necessarily indicate a personal connection.
Carl B. Feldbaum

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

William Hinshaw

President & Chief Executive Officer at Axcella Health, Inc.

Relationship likelihood: Strong

Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Relationship likelihood: Strong

Andrew Dickinson

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Brett A. Pletcher

Executive Vice President, Corporate Affairs & General Counsel at Gilead Sciences, Inc.

Relationship likelihood: Strong

Joshua Kazam

Co-Founder at VV Manager LLC

Relationship likelihood: Strong

Robin L. Washington

Chief Financial Officer at Kite Pharma, Inc.

Relationship likelihood: Strong

James Sapirstein

Interim Chief Executive Officer at Marizyme, Inc.

Relationship likelihood: Strong

Paul Hudson

Chief Executive Officer at Sanofi

Relationship likelihood: Strong

James R. Meyers

President & Chief Executive Officer at IntraBio

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
FiercePharma
March 8, 2021
Gilead's CAR-T med Yescarta gets a leg up on Novartis rival with FDA nod in follicular lymphoma
Nasdaq
March 8, 2021
Gilead’s Kite Receives FDA Approval For Yescarta Immunotherapy; Street Sees 17
Business Wire
March 5, 2021
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy; -- Yescarta is the First CAR T-Cell Therapy Approved for Indolent Follicular Lymphoma; Approval Marks the Third Indication for a Kite C
Business Wire
February 8, 2021
Kite Appoints Frank Neumann as Worldwide Head of Clinical Development; -- Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite's Clinical Programs --
Nasdaq
February 5, 2021
Gilead Sciences (GILD) Q4 2020 Earnings Call Transcript
Trending People
Prince Philip, Duke of Edinburgh
The day King Edward caught Prince Philip's ear; Many Telegraph readers have had... - The Daily Telegraph (London)
Merrick B. Garland
Biden's appeals for action on guns, policing face reality - The Independent UK
Matt Gaetz
New conservative group would save 'Anglo-Saxon' traditions - Associated Press
Jennifer Rene Psaki
Biden Wavers on Restricting Refugee Entry - The New York Times
Vladimir Vladimirovich Putin
PUTIN BLOCKS OFF FOREIGN WARSHIPS - The Daily Mail and Mail on Sunday (London)
Trending People
Prince Philip, Duke of Edinburgh
The day King Edward caught Prince Philip's ear; Many Telegraph readers have had... - The Daily Telegraph (London)
Merrick B. Garland
Biden's appeals for action on guns, policing face reality - The Independent UK
Matt Gaetz
New conservative group would save 'Anglo-Saxon' traditions - Associated Press
Jennifer Rene Psaki
Biden Wavers on Restricting Refugee Entry - The New York Times
Vladimir Vladimirovich Putin
PUTIN BLOCKS OFF FOREIGN WARSHIPS - The Daily Mail and Mail on Sunday (London)
Paths to Christi Shaw
Potential Connections via
Relationship Science
You
Christi Shaw
Chief Executive Officer, Kite at Gilead Sciences, Inc.
Education
University of Wisconsin - Madison

The University of Wisconsin–Madison has long been recognized as one of America's great universities. A public, land-grant institution, UW–Madison offers a complete spectrum of liberal arts studies, professional programs and student activities. Spanning 936 acres along the southern shore of Lake Mendota, the campus is located in the city of Madison.

Iowa State University

Iowa State is an international university with a friendly welcoming personality. Students from all 50 states and more than 100 countries come to Ames, Iowa, to choose from 100 majors, study with world-class scholars and hone their leadership skills in 800-plus student organizations. Iowa State offers a great environment where students can enjoy reaching their potential and discovering their passions.

Career History
Chief Executive Officer
2019 - Current
Kite Pharma, Inc.

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam in June 2009 and is headquartered in Santa Monica, CA.

Chief Executive Officer, Kite
2019 - Current
Gilead Sciences, Inc.

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Senior Vice President & President, Lilly Bio-Medicines
2017 - 2019
Eli Lilly & Company

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Boards & Committees
Member, Board of Directors
Prior - 2016
Choose New Jersey, Inc.

Choose New Jersey is a nonprofit company headquartered in Princeton, NJ, that provides economic development services. The firm was founded by Robert J. Hugin.The company says this about itself: Choose New Jersey is a privately funded 501(c)(3) nonprofit economic development organization. Our mission is to stimulate job creation and attract capital investment to New Jersey. We market New Jersey both domestically and internationally as the best place to grow your business in the United States. Our knowledgeable, experienced staff, supported by a network of State agencies and private partners, provide free, confidential assistance to guide companies in establishing operations here. By harnessing the power of business, labor, academic and government leaders, we enable growth across all sectors of our State's economy. We aspire to build a stronger and more prosperous New Jersey for all.
Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Christi Shaw is affiliated with Kite Pharma, Inc., Gilead Sciences, Inc., Eli Lilly & Company, Novartis Corporation, Novartis Pharmaceuticals Corp., Ethicon Corp., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Choose New Jersey, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christi Shaw. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christi Shaw's profile does not indicate a business or promotional relationship of any kind between RelSci and Christi Shaw.